L Kaizer
Overview
Explore the profile of L Kaizer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
454
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horvath Z, Paszt A, Simonka Z, Latos M, Kaizer L, Hamar S, et al.
Eur J Surg Oncol
. 2019 Nov;
46(4 Pt A):504-510.
PMID: 31708307
Introduction: Based on international guidelines, axillary lymph node dissection (ALND) is recommended in cases of breast cancer if preoperative examinations confirm axillary metastasis. We examined which set of preoperative parameters...
2.
Horvath Z, Paszt A, Simonka Z, Latos M, Olah V, Nagyszegi D, et al.
Eur J Surg Oncol
. 2017 Feb;
43(7):1252-1257.
PMID: 28139361
Introduction: Intraoperative touch imprint cytology (TIC) of the sentinel lymph node(s) (SLN(s)) in the treatment of breast cancer has significantly reduced the number of axillary block dissections (ABD) required during...
3.
DAVISON K, Chen B, Kukreti V, Couban S, Benger A, Berinstein N, et al.
Ann Oncol
. 2016 Dec;
28(3):622-627.
PMID: 27993811
Background: High-dose therapy and autologous stem cell transplantation (ASCT) is often considered for older patients (age >60 years) with relapsed/refractory aggressive lymphomas. Although registry data support the safety and potential...
4.
Evans J, Qiu M, MacKinnon M, Green E, Peterson K, Kaizer L
Eur J Cancer Care (Engl)
. 2015 Nov;
25(5):883-902.
PMID: 26545409
This study summarises research- and practice-based evidence on home-based chemotherapy, and explores existing delivery models. A three-pronged investigation was conducted consisting of a literature review and synthesis of 54 papers,...
5.
Kelemen G, Farkas V, Debrah J, Ormandi K, Voros A, Kaizer L, et al.
Neoplasma
. 2012 Jun;
59(5):566-73.
PMID: 22668023
The presence of multifocality and the aggregate tumor size were retrospectively analysed in a database of 1071 operated breast cancers. Around a quarter of all these cancers involved multiple foci,...
6.
Goss P, Strasser K, Marques R, Clemons M, Oza A, Goel R, et al.
Breast Cancer Res Treat
. 2001 Feb;
64(2):177-88.
PMID: 11194453
Three phase II studies were conducted to determine the efficacy and tolerability of liarozole fumarate (R85246; liarozole), a retinoic acid metabolism blocking agent (RAMBA) and aromatase inhibitor. Additionally, animal experiments...
7.
Goss P, Stewart A, Couture F, Klasa R, Gluck S, Kaizer L, et al.
Leuk Lymphoma
. 1999 Aug;
34(3-4):295-304.
PMID: 10439366
This study was performed to determine the clinical activity and safety of paclitaxel in the treatment of patients with refractory or relapsing aggressive Non-Hodgkin's lymphoma (NHL). Between May 3, 1994...
8.
Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J
Support Care Cancer
. 1997 Jul;
5(4):307-13.
PMID: 9257427
The purpose was to measure the effects of postchemotherapy nausea and vomiting (PCNV) on health-related quality of life (HQL) in patients receiving either moderately or highly emetogenic chemotherapy. The study...
9.
Dancey J, Zee B, Osoba D, Whitehead M, Lu F, Kaizer L, et al.
Qual Life Res
. 1997 Mar;
6(2):151-8.
PMID: 9161115
This report examines the prognostic associations between QOL scores measured by the EORTC QLQ-C30 and survival in a large heterogeneous population of cancer patients. Eight hundred and fifty-one cancer patients...
10.
Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L
J Clin Oncol
. 1997 Jan;
15(1):116-23.
PMID: 8996132
Purpose: To assess whether prechemotherapy health-related quality-of-life (HQL) variables are associated with postchemotherapy nausea and vomiting (PCNV), and to determine their relationship to patient and treatment variables. Patients And Methods:...